Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Electroencephalography Evaluation in Caffeine Discontinuation Timing in Premature Infants

NCT07324941 is registered in ClinicalTrials.gov with Uludag University as lead sponsor.

NCT NCT07324941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07324941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Electroencephalography Evaluation in Caffeine Discontinuation Timing in Premature Infants
Lead sponsor
Uludag University
Phase
Observational
Overall status
Recruiting
Start date
January 2, 2026
Completion date
January 2, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apnea neonatal, apnea of prematurity